MedTrace Logo

Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia

NCT02585635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2018-03-29

No results posted yet for this study

Summary

The MOrPH study is designed to identify optimal prophylaxis schedules for children with haemophilia. This involves development of combined pharmacokinetic and pharmacodynamic models. Interpretation of model outputs will be informed by two surveys. The first will survey families of children with haemophilia to ascertain families' values and preferences concerning prophylaxis schedules. The second will survey haemophilia physicians to ascertain the criteria physicians use to prescribe prophylaxis schedules.

Conditions

Sponsors & Collaborators

  • Sydney Children's Hospitals Network

    collaborator OTHER

  • The George Institute

    collaborator OTHER

  • Royal Children's Hospital

    collaborator OTHER

  • Neuroscience Research Australia

    lead OTHER

Principal Investigators

  • Rob Herbert, PhD · Neuroscience Research Australia

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-02-01
Completion
2018-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02585635 on ClinicalTrials.gov